Funded Tech Companies

Immusoft

Immusoft is a biopharmaceutical company, located in Seattle. Venture capital investment was provided by California Institute for Regenerative Medicine, Alexandria Venture Investments and DEFTA Partners.

Company Overview

Contact Information

Company Background Information

Overview

Immusoft's mission is to develop a breakthrough autologous cell therapy platform for treating a variety of human diseases through our proprietary Immune System Programming (ISP) technology. ISP technology can effectively re-program a patient's own cells to become miniature drug factories in the body.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

1/31/2023

Financing History

Management Team

Title

Name

Email & Social

Chief Executive Officer

Sean Ainsworth

        

Chief Scientific Officer

Robert Hayes

        

VP - Bus. Development

Cam Gallagher

        

VP - Bus. Development

Scott McIvor

        

VP - Regulatory Affairs

Monika Swietlicka

        

Company Investors

• California Institute for Regenerative Medicine
• Alexandria Venture Investments
• DEFTA Partners
• RBV Capital
• Breakout Capital
• Mesa Verde Venture Partners
• Founders Fund (Peter Thiel)
• Technium Partners
• 600 Mile Challenge Fund
• Private Investors (Timothy Draper)

Browse more funded tech companies:

ImmusanT | Immuta

Share this article

About Our VC Deals Database

Our data comes from VentureDeal.com, a leading provider of venture capital transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary